Navigation Links
Frost & Sullivan: Pharma and Biotech Industries Headed Toward an Era of Reduced Profit Margins
Date:5/2/2013

ontact">Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
NBB7-F1

Contact:
Britni Myers
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003
E: britni.myers@frost.com 
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
2. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
3. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
4. Frost & Sullivan Research Preview: Top 20 Telehealth Markets
5. Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan
6. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
7. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
8. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
11. Frost & Sullivan to Host Complimentary Web Conference: Concerns and Solutions for the Anaesthesia Equipment and Associated Peripherals Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... MONROVIA, Calif., July 31, 2014 Xencor ... biopharmaceutical company developing engineered monoclonal antibodies for the ... and cancer, today reported financial results for the ... review of recent business highlights. "In ... the American Thoracic Society 2014 International Conference (ATS) ...
(Date:7/31/2014)... , July 31, 2014  Cepheid (NASDAQ: CPHD ... the following conferences, and invited investors to participate via webcast. ... New York, NY Wednesday, August 13, ... Health Care Conference, New York, NY ... Accessing Live Webcasts To access the live webcasts ...
(Date:7/31/2014)... , July 31, 2014  Alexza Pharmaceuticals, ... an update on its pipeline and new product ... expects to initiate a Phase 2a study of ... developed for the management of patients with acute ... Staccato -based product candidates for development - ...
Breaking Medicine Technology:Xencor Reports Second Quarter 2014 Financial Results 2Xencor Reports Second Quarter 2014 Financial Results 3Xencor Reports Second Quarter 2014 Financial Results 4Xencor Reports Second Quarter 2014 Financial Results 5Xencor Reports Second Quarter 2014 Financial Results 6Xencor Reports Second Quarter 2014 Financial Results 7Xencor Reports Second Quarter 2014 Financial Results 8Cepheid to Webcast Upcoming Financial Presentations 2Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6
(Date:8/1/2014)... 2014 A new study published ... may contribute to the development of colorectal cancer in ... The study was authored by Alberto Martin of the ... cause intestinal cells to multiply and create tumors in ... , “What’s interesting about this study,” said Shahab ...
(Date:8/1/2014)... Canadian, OK (PRWEB) August 01, 2014 ... graduate from the program at the drug rehab center ... in the year 2001, Narconon Arrowhead is the flagship ... come from across the United States for services there. ... the center has recent outcome studies as well as ...
(Date:8/1/2014)... York (PRWEB) August 01, 2014 ... recently announced the addition of a comprehensive report ... titled ‘Infusion System Market (Large Volume, Disposable, Syringe, ... Share, Growth, Trends And Forecast, 2013 – 2019’ ... website http://www.transparencymarketresearch.com . , To begin with, ...
(Date:8/1/2014)... HealthDay Reporter , THURDAY, July ... healthier than school cafeteria fare, a new study suggests. ... lunches third and fourth graders brought from home met three ... "Our findings are similar to results of other studies of ... that high-calorie packaged foods and beverages are more common than ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- Although older women ... make asthma care a priority, according to a new study. ... from asthma much more than men over 65," concluded Dr. ... of Allergy, Asthma and Immunology (ACAAI), in an organization news ... age 65 years and older is nearly four times higher ...
Breaking Medicine News(10 mins):Health News:Carbs May Contribute to Colon Cancer 2Health News:Narconon Arrowhead Celebrates 4,300th Graduate from Program 2Health News:Narconon Arrowhead Celebrates 4,300th Graduate from Program 3Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 2Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 3Health News:Older Women With Asthma Face Worse Health Outcomes 2
... April 22 Aida,Pharmaceuticals, Inc. (OTC Bulletin ... investor-focused corporate synopsis on its English,language website, ... as a,pdf document. The synopsis details Aida ... line, the drugs in its,development pipeline, as ...
... leads to adverse reactions identified, officials add , , MONDAY, ... now been found in at least 10 countries, not ... to ensure the safety of the blood thinner, U.S. ... contaminated lots of the blood thinner have been traced ...
... Available in Smaller Package for Healthy Snacking, MINDEN, ... the maker of the award-winning Detour(R) bar, today announced,the ... their top,selling Detour Caramel Peanut Bar(TM). The snack size ... choice for energy seekers living a,healthy lifestyle. With seven ...
... The American College of Allergy,Asthma & Immunology ... surveys that highlight the importance of improving care ... and other important,information for physicians and patients are ... like Sepracor who are,committed to driving the dialogue ...
... SAN JUAN, Puerto Rico, April 22 Triple-S,Management Corporation ... plans,to release financial results for the first quarter ended ... 2008. Ramon M. Ruiz-Comas, President and,Chief Executive Officer, and ... host a conference call to discuss these,results and the ...
... Formation Capital, LLC is,pleased to announce that ... joined the company as Senior Executive Vice President ... be leading the day-to-day,operations and direction of the ... leading change, building shareholder value, and managing Board,and ...
Cached Medicine News:Health News:Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website 2Health News:FDA: Contaminated Heparin Found in 11 Countries 2Health News:FDA: Contaminated Heparin Found in 11 Countries 3Health News:FDA: Contaminated Heparin Found in 11 Countries 4Health News:Detour(R) Unveils Snack Size Protein Bar 2Health News:Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast 2Health News:Damian Dell'Anno Joins Formation Capital as Chief Operating Officer 2
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
S.O.C. Medium...
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
Medicine Products: